CH Cote Basque — Bayonne

Public research footprint of CH Cote Basque, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

HER2-(Ultra)Low Expressing Breast Cancer · Unresectable Colorectal Cancer · Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome… · Risk-Adapted and MRD-Driven Strategy

Recently updated registry entries

NCT05945732 — DESTINY Breast Respond HER2-(Ultra)Low Europe (Recruiting)
NCT03249870 — Study of Inotuzumab Ozogamicin Combined to Chemotherapy in Older Patients With… (Completed)
NCT06475352 — Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CH Cote Basque?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.